Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer.

Berger AP, Deibl M, Strasak A, Bektic J, Pelzer AE, Klocker H, Steiner H, Fritsche G, Bartsch G, Horninger W.

Urology. 2007 Jan;69(1):134-8.

PMID:
17270635
2.

Population screening for prostate cancer and emerging concepts for young men.

Moul JW.

Clin Prostate Cancer. 2003 Sep;2(2):87-97. Review.

PMID:
15040869
3.

Prostate-specific antigen as a screening test for prostate cancer. The United States experience.

Arcangeli CG, Ornstein DK, Keetch DW, Andriole GL.

Urol Clin North Am. 1997 May;24(2):299-306. Review.

PMID:
9126227
4.

Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.

Schröder FH, Roobol MJ.

Curr Opin Urol. 2009 May;19(3):227-31. doi: 10.1097/MOU.0b013e328329a2d0. Review.

PMID:
19357513
5.

The role of prostate-specific antigen in the chemoprevention of prostate cancer.

Crawford ED, DeAntoni EP, Ross CA.

J Cell Biochem Suppl. 1996;25:149-55. Review.

PMID:
9027612
6.

Prostate-specific antigen velocity (PSAV): a practical role for PSA?

Thanigasalam R, Mancuso P, Tsao K, Rashid P.

ANZ J Surg. 2009 Oct;79(10):703-6. doi: 10.1111/j.1445-2197.2009.05055.x. Review.

PMID:
19878164
7.

PSA testing: an evolving relationship with prostate cancer screening.

Constantinou J, Feneley MR.

Prostate Cancer Prostatic Dis. 2006;9(1):6-13. Review.

PMID:
16314892
8.

[The clinical value of prostate-specific antigen velocity as a method for prostate cancer detection].

Ito K, Kubota Y, Yamanaka H.

Nihon Rinsho. 1998 Aug;56(8):2021-5. Review. Japanese.

PMID:
9750500
9.

Screening for prostate cancer: who and how often?

Schwartz K, Deschere B, Xu J.

J Fam Pract. 2005 Jul;54(7):586-96. Review.

PMID:
16009085
10.

The role of prostate-specific antigen velocity in prostate cancer early detection.

Potter SR, Carter HB.

Curr Urol Rep. 2000 May;1(1):15-9. Review.

PMID:
12084336
11.

PSA level changes over time in men with an initial PSA level of < or = 4 ng/ml.

Bangma C.

Nat Clin Pract Urol. 2006 Oct;3(10):520-1. Review. No abstract available.

PMID:
17031372
12.

PSA velocity: a systematic review of clinical applications.

Loughlin KR.

Urol Oncol. 2014 Nov;32(8):1116-25. doi: 10.1016/j.urolonc.2014.04.010. Epub 2014 Jun 25. Review.

PMID:
24974369
13.

[Screening for prostate cancer: arguments "against"].

Perrin P.

Ann Urol (Paris). 2006 Apr;40(2):101-5. Review. French.

PMID:
16709008
14.

The rise and fall of PSA: clinical implications of prostate specific antigen kinetics.

Semjonow A, Schmid HP.

Urol Res. 2002 May;30(2):85-8. Review. No abstract available.

PMID:
12086020

Supplemental Content

Support Center